12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Deals

Proteonomix Inc., University of Miami deal

Proteonomix and the university will conduct a clinical study to test UMK-121 in patients with end-stage liver disease. The...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >